Literature DB >> 12044979

Abrupt or precipitated withdrawal from morphine induces immunosuppression.

Rahil T Rahim1, Martin W Adler, Joseph J Meissler, Alan Cowan, Thomas J Rogers, Ellen B Geller, Toby K Eisenstein.   

Abstract

The present studies tested the effect of withdrawal from morphine by two different paradigms, abrupt withdrawal (AW) or precipitated withdrawal (PW), on the capacity of murine spleen cells to mount an in vitro antibody response. Mice were made dependent by chronic treatment using s.c. implanted morphine slow-release pellets. Splenocytes were harvested at various time points after withdrawal and the number of antibody-forming cells determined using a plaque-forming cell (PFC) assay. The results indicate that induction of abstinence from morphine in dependent mice by either paradigm caused marked immunosuppression between 24 and 48 h post-withdrawal. However, the kinetics of onset and recovery from immunosuppression were different in AW and PW.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12044979     DOI： 10.1016/s0165-5728(02)00103-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN： 0165-5728            Impact factor:   3.478


  17 in total

Review 1.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

Review 2.  Effects of opioid tolerance and withdrawal on the immune system.

Authors:  Toby K Eisenstein; Rahil T Rahim; Pu Feng; Nita K Thingalaya; Joseph J Meissler
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-23       Impact factor: 4.147

3.  Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12.

Authors:  Pu Feng; Qiana M Wilson; Joseph J Meissler; Martin W Adler; Toby K Eisenstein
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 4.  Immunosuppressive effects of opioids--clinical relevance.

Authors:  Alexander Brack; Heike L Rittner; Christoph Stein
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-05       Impact factor: 4.147

5.  Morphine withdrawal stress modulates lipopolysaccharide-induced interleukin 12 p40 (IL-12p40) expression by activating extracellular signal-regulated kinase 1/2, which is further potentiated by glucocorticoids.

Authors:  Subhas Das; Jennifer Kelschenbach; Richard Charboneau; Roderick A Barke; Sabita Roy
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

6.  Morphine withdrawal enhances hepatitis C virus replicon expression.

Authors:  Chuan-Qing Wang; Yuan Li; Steven D Douglas; Xu Wang; David S Metzger; Ting Zhang; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

7.  The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use.

Authors:  Farzana Kapadia; Judith A Cook; Marge H Cohen; Nancy Sohler; Andrea Kovacs; Ruth M Greenblatt; Imtiaz Choudhary; David Vlahov
Journal:  Addiction       Date:  2005-07       Impact factor: 6.526

8.  Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal.

Authors:  Virginia D McLane; Ivy Bergquist; James Cormier; Deborah J Barlow; Karen L Houseknecht; Edward J Bilsky; Ling Cao
Journal:  Life Sci       Date:  2017-07-16       Impact factor: 5.037

9.  An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P.

Authors:  Xu Wang; Steven D Douglas; Jin-Song Peng; Dun-Jin Zhou; Qi Wan; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 10.  Intensive Care Unit-acquired infection as a side effect of sedation.

Authors:  Saad Nseir; Demosthenes Makris; Daniel Mathieu; Alain Durocher; Charles-Hugo Marquette
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.